APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laboratory Developed Tests (LDT)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Laboratory Developed Tests (LDT) Market Analysis and Forecast 2026-2032

16 January 2026192 pages

Choose your research edition.

Industry ResearchLaboratory Developed Tests (LDT) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Laboratory Developed Tests (LDT) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Laboratory Developed Tests (LDT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laboratory Developed Tests (LDT) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Laboratory Developed Tests (LDT) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Laboratory Developed Tests (LDT) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Laboratory Developed Tests (LDT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Laboratory Developed Tests (LDT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Laboratory Developed Tests (LDT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Laboratory Developed Tests (LDT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Laboratory Developed Tests (LDT) include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health and Adaptive Biotechnologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Laboratory Developed Tests (LDT), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Laboratory Developed Tests (LDT), also provides the revenue of main regions and countries. Of the upcoming market potential for Laboratory Developed Tests (LDT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Laboratory Developed Tests (LDT) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Laboratory Developed Tests (LDT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Laboratory Developed Tests (LDT) revenue, projected growth trends, production technology, application and end-user industry.

Laboratory Developed Tests (LDT) Segment by Company

Quest Diagnostics

Thermo Fisher

Waters Corporation

Roche

Illumina

Qiagen

Eurofins

Guardant Health

Adaptive Biotechnologies

Biodesix

Berry Oncology

Genetron Health

Laboratory Developed Tests (LDT) Segment by Type

Clinical Biochemistry

Hematology

Immunology

Molecular Diagnostics

Other

Laboratory Developed Tests (LDT) Segment by Application

Hospitals Laboratory

Clinical Research Organizations

Academic Institutes

Specialty Diagnostic Centers

Other

Laboratory Developed Tests (LDT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory Developed Tests (LDT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory Developed Tests (LDT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory Developed Tests (LDT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Laboratory Developed Tests (LDT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Laboratory Developed Tests (LDT) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory Developed Tests (LDT) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Clinical Biochemistry Major Player Table 3. Hematology Major Player Table 4. Immunology Major Player Table 5. Molecular Diagnostics Major Player Table 6. Other Major Player Table 7. Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Laboratory Major Player Table 9. Clinical Research Organizations Major Player Table 10. Academic Institutes Major Player Table 11. Specialty Diagnostic Centers Major Player Table 12. Other Major Player Table 13. Laboratory Developed Tests (LDT) Industry Trends Table 14. Laboratory Developed Tests (LDT) Industry Drivers Table 15. Laboratory Developed Tests (LDT) Industry Opportunities and Challenges Table 16. Laboratory Developed Tests (LDT) Industry Restraints Table 17. Global Laboratory Developed Tests (LDT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Laboratory Developed Tests (LDT) Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Laboratory Developed Tests (LDT) Market Share by Region (2021-2026) Table 20. Global Laboratory Developed Tests (LDT) Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Laboratory Developed Tests (LDT) Market Share by Region (2027-2032) Table 22. Global Laboratory Developed Tests (LDT) Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Laboratory Developed Tests (LDT) Revenue Market Share by Players (2021-2026) Table 24. Global Laboratory Developed Tests (LDT) Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Laboratory Developed Tests (LDT) Key Players Headquarters & Area Served Table 26. Global Laboratory Developed Tests (LDT) Players, Product Type & Application Table 27. Global Laboratory Developed Tests (LDT) Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Laboratory Developed Tests (LDT) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Laboratory Developed Tests (LDT) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Laboratory Developed Tests (LDT) Revenue Market Share by Type (2021-2026) Table 34. Global Laboratory Developed Tests (LDT) Revenue Market Share by Type (2027-2032) Table 35. Global Laboratory Developed Tests (LDT) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Laboratory Developed Tests (LDT) Revenue Market Share by Application (2021-2026) Table 39. Global Laboratory Developed Tests (LDT) Revenue Market Share by Application (2027-2032) Table 40. Quest Diagnostics Company Information Table 41. Quest Diagnostics Business Overview Table 42. Quest Diagnostics Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio Table 44. Quest Diagnostics Recent Development Table 45. Thermo Fisher Company Information Table 46. Thermo Fisher Business Overview Table 47. Thermo Fisher Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio Table 49. Thermo Fisher Recent Development Table 50. Waters Corporation Company Information Table 51. Waters Corporation Business Overview Table 52. Waters Corporation Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio Table 54. Waters Corporation Recent Development Table 55. Roche Company Information Table 56. Roche Business Overview Table 57. Roche Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Roche Laboratory Developed Tests (LDT) Product Portfolio Table 59. Roche Recent Development Table 60. Illumina Company Information Table 61. Illumina Business Overview Table 62. Illumina Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Illumina Laboratory Developed Tests (LDT) Product Portfolio Table 64. Illumina Recent Development Table 65. Qiagen Company Information Table 66. Qiagen Business Overview Table 67. Qiagen Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Qiagen Laboratory Developed Tests (LDT) Product Portfolio Table 69. Qiagen Recent Development Table 70. Eurofins Company Information Table 71. Eurofins Business Overview Table 72. Eurofins Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Eurofins Laboratory Developed Tests (LDT) Product Portfolio Table 74. Eurofins Recent Development Table 75. Guardant Health Company Information Table 76. Guardant Health Business Overview Table 77. Guardant Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Guardant Health Laboratory Developed Tests (LDT) Product Portfolio Table 79. Guardant Health Recent Development Table 80. Adaptive Biotechnologies Company Information Table 81. Adaptive Biotechnologies Business Overview Table 82. Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio Table 84. Adaptive Biotechnologies Recent Development Table 85. Biodesix Company Information Table 86. Biodesix Business Overview Table 87. Biodesix Laboratory Developed Tests (LDT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Biodesix Laboratory Developed Tests (LDT) Product Portfolio Table 89. Biodesix Recent Development Table 90. Berry Oncology Company Information Table 91. Berry Oncology Business Overview Table 92. Berry Oncology Laboratory Developed Tests (LDT) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio Table 94. Berry Oncology Recent Development Table 95. Genetron Health Company Information Table 96. Genetron Health Business Overview Table 97. Genetron Health Laboratory Developed Tests (LDT) Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Genetron Health Laboratory Developed Tests (LDT) Product Portfolio Table 99. Genetron Health Recent Development Table 100. North America Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Laboratory Developed Tests (LDT) Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Laboratory Developed Tests (LDT) Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Laboratory Developed Tests (LDT) Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Laboratory Developed Tests (LDT) Revenue by Country (US$ Million) & (2027-2032) Table 114. China Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 115. China Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 116. China Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 117. China Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Laboratory Developed Tests (LDT) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Laboratory Developed Tests (LDT) Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Laboratory Developed Tests (LDT) Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Laboratory Developed Tests (LDT) Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Laboratory Developed Tests (LDT) Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Laboratory Developed Tests (LDT) Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Laboratory Developed Tests (LDT) Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Laboratory Developed Tests (LDT) Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Laboratory Developed Tests (LDT) Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Laboratory Developed Tests (LDT) Image Figure 2. Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory Developed Tests (LDT) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Clinical Biochemistry Image Figure 5. Hematology Image Figure 6. Immunology Image Figure 7. Molecular Diagnostics Image Figure 8. Other Image Figure 9. Global Laboratory Developed Tests (LDT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Laboratory Developed Tests (LDT) Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Laboratory Image Figure 12. Clinical Research Organizations Image Figure 13. Academic Institutes Image Figure 14. Specialty Diagnostic Centers Image Figure 15. Other Image Figure 16. Global Laboratory Developed Tests (LDT) Market Size (US$ Million) & (2021-2032) Figure 17. Global Laboratory Developed Tests (LDT) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Laboratory Developed Tests (LDT) Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Laboratory Developed Tests (LDT) Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Laboratory Developed Tests (LDT) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Laboratory Developed Tests (LDT) Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Laboratory Developed Tests (LDT) Revenue Market Share by Type (2021-2032) Figure 24. Global Laboratory Developed Tests (LDT) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Laboratory Developed Tests (LDT) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Laboratory Developed Tests (LDT) Revenue Market Share by Application (2021-2032) Figure 27. North America Laboratory Developed Tests (LDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032) Figure 29. North America Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032) Figure 30. North America Laboratory Developed Tests (LDT) Revenue Share by Country (2021-2032) Figure 31. United States Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Laboratory Developed Tests (LDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032) Figure 36. Europe Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032) Figure 37. Europe Laboratory Developed Tests (LDT) Revenue Share by Country (2021-2032) Figure 38. Germany Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Laboratory Developed Tests (LDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032) Figure 48. China Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032) Figure 49. Asia Laboratory Developed Tests (LDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032) Figure 51. Asia Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032) Figure 52. Asia Laboratory Developed Tests (LDT) Revenue Share by Region (2021-2032) Figure 53. Japan Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Laboratory Developed Tests (LDT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032) Figure 61. SAMEA Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032) Figure 62. SAMEA Laboratory Developed Tests (LDT) Revenue Share by Country (2021-2032) Figure 63. Brazil Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Laboratory Developed Tests (LDT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Clinical Biochemistry
  • Hematology
  • Immunology
  • Molecular Diagnostics
  • Other
Applications
  • Hospitals Laboratory
  • Clinical Research Organizations
  • Academic Institutes
  • Specialty Diagnostic Centers
  • Other
Companies covered
  • Quest Diagnostics
  • Thermo Fisher
  • Waters Corporation
  • Roche
  • Illumina
  • Qiagen
  • Eurofins
  • Guardant Health
  • Adaptive Biotechnologies
  • Biodesix
  • Berry Oncology
  • Genetron Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Laboratory Developed Tests (LDT) Market by Type
  3. 1.2.1 Global Laboratory Developed Tests (LDT) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Clinical Biochemistry
  5. 1.2.3 Hematology
  6. 1.2.4 Immunology
  7. 1.2.5 Molecular Diagnostics
  8. 1.2.6 Other
  9. 1.3 Laboratory Developed Tests (LDT) Market by Application
  10. 1.3.1 Global Laboratory Developed Tests (LDT) Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals Laboratory
  12. 1.3.3 Clinical Research Organizations
  13. 1.3.4 Academic Institutes
  14. 1.3.5 Specialty Diagnostic Centers
  15. 1.3.6 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Laboratory Developed Tests (LDT) Market Dynamics
  1. 2.1 Laboratory Developed Tests (LDT) Industry Trends
  2. 2.2 Laboratory Developed Tests (LDT) Industry Drivers
  3. 2.3 Laboratory Developed Tests (LDT) Industry Opportunities and Challenges
  4. 2.4 Laboratory Developed Tests (LDT) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Laboratory Developed Tests (LDT) Market Perspective (2021-2032)
  2. 3.2 Global Laboratory Developed Tests (LDT) Growth Trends by Region
  3. 3.2.1 Global Laboratory Developed Tests (LDT) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Laboratory Developed Tests (LDT) Market Size by Region (2021-2026)
  5. 3.2.3 Global Laboratory Developed Tests (LDT) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Laboratory Developed Tests (LDT) Revenue by Players
  2. 4.1.1 Global Laboratory Developed Tests (LDT) Revenue by Players (2021-2026)
  3. 4.1.2 Global Laboratory Developed Tests (LDT) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Laboratory Developed Tests (LDT) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Laboratory Developed Tests (LDT) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Laboratory Developed Tests (LDT) Key Players Headquarters & Area Served
  7. 4.4 Global Laboratory Developed Tests (LDT) Players, Product Type & Application
  8. 4.5 Global Laboratory Developed Tests (LDT) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Laboratory Developed Tests (LDT) Market CR5 and HHI
  11. 4.6.3 2025 Laboratory Developed Tests (LDT) Tier 1, Tier 2, and Tier 3
5 Laboratory Developed Tests (LDT) Market Size by Type
  1. 5.1 Global Laboratory Developed Tests (LDT) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 5.3 Global Laboratory Developed Tests (LDT) Revenue Market Share by Type (2021-2032)
6 Laboratory Developed Tests (LDT) Market Size by Application
  1. 6.1 Global Laboratory Developed Tests (LDT) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  3. 6.3 Global Laboratory Developed Tests (LDT) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Quest Diagnostics
  2. 7.1.1 Quest Diagnostics Company Information
  3. 7.1.2 Quest Diagnostics Business Overview
  4. 7.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Product Portfolio
  6. 7.1.5 Quest Diagnostics Recent Developments
  7. 7.2 Thermo Fisher
  8. 7.2.1 Thermo Fisher Company Information
  9. 7.2.2 Thermo Fisher Business Overview
  10. 7.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Product Portfolio
  12. 7.2.5 Thermo Fisher Recent Developments
  13. 7.3 Waters Corporation
  14. 7.3.1 Waters Corporation Company Information
  15. 7.3.2 Waters Corporation Business Overview
  16. 7.3.3 Waters Corporation Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Waters Corporation Laboratory Developed Tests (LDT) Product Portfolio
  18. 7.3.5 Waters Corporation Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Roche Laboratory Developed Tests (LDT) Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Illumina
  26. 7.5.1 Illumina Company Information
  27. 7.5.2 Illumina Business Overview
  28. 7.5.3 Illumina Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Illumina Laboratory Developed Tests (LDT) Product Portfolio
  30. 7.5.5 Illumina Recent Developments
  31. 7.6 Qiagen
  32. 7.6.1 Qiagen Company Information
  33. 7.6.2 Qiagen Business Overview
  34. 7.6.3 Qiagen Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Qiagen Laboratory Developed Tests (LDT) Product Portfolio
  36. 7.6.5 Qiagen Recent Developments
  37. 7.7 Eurofins
  38. 7.7.1 Eurofins Company Information
  39. 7.7.2 Eurofins Business Overview
  40. 7.7.3 Eurofins Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eurofins Laboratory Developed Tests (LDT) Product Portfolio
  42. 7.7.5 Eurofins Recent Developments
  43. 7.8 Guardant Health
  44. 7.8.1 Guardant Health Company Information
  45. 7.8.2 Guardant Health Business Overview
  46. 7.8.3 Guardant Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Guardant Health Laboratory Developed Tests (LDT) Product Portfolio
  48. 7.8.5 Guardant Health Recent Developments
  49. 7.9 Adaptive Biotechnologies
  50. 7.9.1 Adaptive Biotechnologies Company Information
  51. 7.9.2 Adaptive Biotechnologies Business Overview
  52. 7.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product Portfolio
  54. 7.9.5 Adaptive Biotechnologies Recent Developments
  55. 7.10 Biodesix
  56. 7.10.1 Biodesix Company Information
  57. 7.10.2 Biodesix Business Overview
  58. 7.10.3 Biodesix Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Biodesix Laboratory Developed Tests (LDT) Product Portfolio
  60. 7.10.5 Biodesix Recent Developments
  61. 7.11 Berry Oncology
  62. 7.11.1 Berry Oncology Company Information
  63. 7.11.2 Berry Oncology Business Overview
  64. 7.11.3 Berry Oncology Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Berry Oncology Laboratory Developed Tests (LDT) Product Portfolio
  66. 7.11.5 Berry Oncology Recent Developments
  67. 7.12 Genetron Health
  68. 7.12.1 Genetron Health Company Information
  69. 7.12.2 Genetron Health Business Overview
  70. 7.12.3 Genetron Health Laboratory Developed Tests (LDT) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Genetron Health Laboratory Developed Tests (LDT) Product Portfolio
  72. 7.12.5 Genetron Health Recent Developments
8 North America
  1. 8.1 North America Laboratory Developed Tests (LDT) Revenue (2021-2032)
  2. 8.2 North America Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 8.2.1 North America Laboratory Developed Tests (LDT) Revenue by Type (2021-2026)
  4. 8.2.2 North America Laboratory Developed Tests (LDT) Revenue by Type (2027-2032)
  5. 8.3 North America Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032)
  6. 8.4 North America Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  7. 8.4.1 North America Laboratory Developed Tests (LDT) Revenue by Application (2021-2026)
  8. 8.4.2 North America Laboratory Developed Tests (LDT) Revenue by Application (2027-2032)
  9. 8.5 North America Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032)
  10. 8.6 North America Laboratory Developed Tests (LDT) Revenue by Country
  11. 8.6.1 North America Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Laboratory Developed Tests (LDT) Revenue by Country (2021-2026)
  13. 8.6.3 North America Laboratory Developed Tests (LDT) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Laboratory Developed Tests (LDT) Revenue (2021-2032)
  2. 9.2 Europe Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Laboratory Developed Tests (LDT) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Laboratory Developed Tests (LDT) Revenue by Type (2027-2032)
  5. 9.3 Europe Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Laboratory Developed Tests (LDT) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Laboratory Developed Tests (LDT) Revenue by Application (2027-2032)
  9. 9.5 Europe Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Laboratory Developed Tests (LDT) Revenue by Country
  11. 9.6.1 Europe Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Laboratory Developed Tests (LDT) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Laboratory Developed Tests (LDT) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Laboratory Developed Tests (LDT) Revenue (2021-2032)
  2. 10.2 China Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 10.2.1 China Laboratory Developed Tests (LDT) Revenue by Type (2021-2026)
  4. 10.2.2 China Laboratory Developed Tests (LDT) Revenue by Type (2027-2032)
  5. 10.3 China Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032)
  6. 10.4 China Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  7. 10.4.1 China Laboratory Developed Tests (LDT) Revenue by Application (2021-2026)
  8. 10.4.2 China Laboratory Developed Tests (LDT) Revenue by Application (2027-2032)
  9. 10.5 China Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Laboratory Developed Tests (LDT) Revenue (2021-2032)
  2. 11.2 Asia Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Laboratory Developed Tests (LDT) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Laboratory Developed Tests (LDT) Revenue by Type (2027-2032)
  5. 11.3 Asia Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Laboratory Developed Tests (LDT) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Laboratory Developed Tests (LDT) Revenue by Application (2027-2032)
  9. 11.5 Asia Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Laboratory Developed Tests (LDT) Revenue by Country
  11. 11.6.1 Asia Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Laboratory Developed Tests (LDT) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Laboratory Developed Tests (LDT) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Laboratory Developed Tests (LDT) Revenue (2021-2032)
  2. 12.2 SAMEA Laboratory Developed Tests (LDT) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Laboratory Developed Tests (LDT) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Laboratory Developed Tests (LDT) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Laboratory Developed Tests (LDT) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Laboratory Developed Tests (LDT) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Laboratory Developed Tests (LDT) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Laboratory Developed Tests (LDT) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Laboratory Developed Tests (LDT) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Laboratory Developed Tests (LDT) Revenue by Country
  11. 12.6.1 SAMEA Laboratory Developed Tests (LDT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Laboratory Developed Tests (LDT) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Laboratory Developed Tests (LDT) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst